Evidence map›Paper›PMID 28759004›Full record

ArticleNature genetics2017

A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF.

Jiyeon Choi, Mai Xu, Matthew M Makowski, Tongwu Zhang, Matthew H Law, Michael A Kovacs, Anton Granzhan, Wendy J Kim, Hemang Parikh, Michael Gartside and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Functional characterization of the 9q34.13 locus identifiesbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Microbiota relationship between breast, colorectal, and lung cancer types.Medical oncology (Northwood, London, England) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. A Double-Edged Sword: The Two Faces of PARylation.International journal of molecular sciences · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 5 countries.

Jiyeon ChoiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Mai XuDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Matthew M MakowskiDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, the Netherlands.
Tongwu ZhangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Matthew H LawQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-4303-8821
Michael A KovacsDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID http://orcid.org/0000-0002-4298-9609
Anton GranzhanCNRS UMR 9187, INSERM U1196, Institut Curie, PSL Research University and Université Paris Sud, Université Paris Saclay, Orsay, France.ORCID http://orcid.org/0000-0002-0424-0461
Wendy J KimDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Hemang ParikhDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Michael GartsideQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Jeffrey M TrentTranslational Genomics Research Institute, Phoenix, Arizona, USA.
Marie-Paule Teulade-FichouCNRS UMR 9187, INSERM U1196, Institut Curie, PSL Research University and Université Paris Sud, Université Paris Saclay, Orsay, France.
Mark M IlesSection of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
Julia A Newton-BishopSection of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
D Timothy BishopSection of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0002-8752-8785
Stuart MacGregorQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0001-6731-8142
Nicholas K HaywardQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Michiel VermeulenDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0003-0836-6894
Kevin M BrownDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID http://orcid.org/0000-0002-8558-6711
National Cancer Institute · USQIMR Berghofer Medical Research Institute · AUUniversity of Leeds · GBRadboud University Nijmegen · NLUniversité Paris-Sud · FRTranslational Genomics Research Institute · USUniversity of South Florida · US

Funding

Cancer Research UK 10589Cancer Research UK 19167
6 · The paper itself

Abstract

Previous genome-wide association studies have identified a melanoma-associated locus at 1q42.1 that encompasses a ∼100-kb region spanning the PARP1 gene. Expression quantitative trait locus (eQTL) analysis in multiple cell types of the melanocytic lineage consistently demonstrated that the 1q42.1 melanoma risk allele (rs3219090[G]) is correlated with higher PARP1 levels. In silico fine-mapping and functional validation identified a common intronic indel, rs144361550 (-/GGGCCC; r

Indexed as

Polymorphism, Single NucleotideBase SequenceCell Line, TumorCell ProliferationCells, CulturedCell Transformation, NeoplasticCellular SenescenceGene Expression ProfilingGene Expression Regulation, NeoplasticHumansImmunoblottingINDEL MutationIntronsMelanocytesMelanomaMicrophthalmia-Associated Transcription FactorBRAF protein, humanMicrophthalmia-Associated Transcription FactorMITF protein, humanPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Proto-Oncogene Proteins B-rafTelomeraseTERT protein, human

Identifiers

PMID28759004
OpenAlexW2740245281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.